FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220764377> ?p ?o ?g. }

• W4220764377 endingPage "429" @default.
• W4220764377 startingPage "421" @default.
• W4220764377 abstract "Following revision shoulder arthroplasty, postoperative antibiotics are selected before the results of intraoperative cultures become available. We determined infection-free survival, revision-free survival, complications, and patient-reported outcomes for patients selected to receive oral or intravenous (IV) antibiotics after revision arthroplasty.This study included 92 patients who had revision shoulder arthroplasty. IV antibiotics were administered if the surgeon had a high index of suspicion for infection, and oral antibiotics were given if there was a low suspicion. Antibiotic therapy was modified based on intraoperative culture results. Patient-reported outcomes and adverse events were documented at a mean of 4.1 years.In selecting antibiotic therapy, surgeons correctly predicted the presence or absence of multiple positive cultures of specimens from the revision surgery in 72% of the 92 cases. Subsequent re-revision surgery was required in 17 (18%) of the patients; 8 of these 17 patients had ≥2 positive cultures at re-revision. Patients who initially received IV antibiotics and those who initially received oral antibiotics had similar revision-free (p = 0.202) and infection-free (p = 0.155) survivorship. Patients requiring a change from oral to IV antibiotics based on positive cultures had similar survivorship compared with those initially treated with IV antibiotics. The IV and oral antibiotic groups had similar postoperative Simple Shoulder Test (SST), American Shoulder and Elbow Surgeons (ASES), and satisfaction scores. Patients receiving IV antibiotics had a higher rate of antibiotic-related adverse events.Post-revision antibiotic therapy was associated with an infection-free survival rate of 91% at a mean of >4 years of follow-up. Infection-free survival, revision-free survival, and patient-reported outcomes were similar in high-risk patients placed on IV antibiotics and low-risk patients placed on oral antibiotics. Further study is needed to define the indications for IV or oral antibiotics after revision arthroplasty.Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence." @default.
• W4220764377 created "2022-04-03" @default.
• W4220764377 creator A5005486159 @default.
• W4220764377 creator A5011663874 @default.
• W4220764377 creator A5023869217 @default.
• W4220764377 creator A5026505364 @default.
• W4220764377 creator A5047020208 @default.
• W4220764377 creator A5091452352 @default.
• W4220764377 date "2021-11-15" @default.
• W4220764377 modified "2023-09-29" @default.
• W4220764377 title "Oral and IV Antibiotic Administration After Single-Stage Revision Shoulder Arthroplasty" @default.
• W4220764377 cites W1576918597 @default.
• W4220764377 cites W1995912447 @default.
• W4220764377 cites W2034645142 @default.
• W4220764377 cites W2309410168 @default.
• W4220764377 cites W2328968049 @default.
• W4220764377 cites W2513549026 @default.
• W4220764377 cites W2888520622 @default.
• W4220764377 cites W2914477527 @default.
• W4220764377 cites W2981559716 @default.
• W4220764377 cites W3008206894 @default.
• W4220764377 cites W4250882241 @default.
• W4220764377 doi "https://doi.org/10.2106/jbjs.20.02263" @default.
• W4220764377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34780386" @default.
• W4220764377 hasPublicationYear "2021" @default.
• W4220764377 type Work @default.
• W4220764377 citedByCount "3" @default.
• W4220764377 countsByYear W42207643772022 @default.
• W4220764377 countsByYear W42207643772023 @default.
• W4220764377 crossrefType "journal-article" @default.
• W4220764377 hasAuthorship W4220764377A5005486159 @default.
• W4220764377 hasAuthorship W4220764377A5011663874 @default.
• W4220764377 hasAuthorship W4220764377A5023869217 @default.
• W4220764377 hasAuthorship W4220764377A5026505364 @default.
• W4220764377 hasAuthorship W4220764377A5047020208 @default.
• W4220764377 hasAuthorship W4220764377A5091452352 @default.
• W4220764377 hasConcept C126322002 @default.
• W4220764377 hasConcept C141071460 @default.
• W4220764377 hasConcept C197934379 @default.
• W4220764377 hasConcept C2778336525 @default.
• W4220764377 hasConcept C501593827 @default.
• W4220764377 hasConcept C68312169 @default.
• W4220764377 hasConcept C71924100 @default.
• W4220764377 hasConcept C86803240 @default.
• W4220764377 hasConcept C89423630 @default.
• W4220764377 hasConceptScore W4220764377C126322002 @default.
• W4220764377 hasConceptScore W4220764377C141071460 @default.
• W4220764377 hasConceptScore W4220764377C197934379 @default.
• W4220764377 hasConceptScore W4220764377C2778336525 @default.
• W4220764377 hasConceptScore W4220764377C501593827 @default.
• W4220764377 hasConceptScore W4220764377C68312169 @default.
• W4220764377 hasConceptScore W4220764377C71924100 @default.
• W4220764377 hasConceptScore W4220764377C86803240 @default.
• W4220764377 hasConceptScore W4220764377C89423630 @default.
• W4220764377 hasIssue "5" @default.
• W4220764377 hasLocation W42207643771 @default.
• W4220764377 hasLocation W42207643772 @default.
• W4220764377 hasOpenAccess W4220764377 @default.
• W4220764377 hasPrimaryLocation W42207643771 @default.
• W4220764377 hasRelatedWork W2002120878 @default.
• W4220764377 hasRelatedWork W2003938723 @default.
• W4220764377 hasRelatedWork W2047967234 @default.
• W4220764377 hasRelatedWork W2118496982 @default.
• W4220764377 hasRelatedWork W214433981 @default.
• W4220764377 hasRelatedWork W2364998975 @default.
• W4220764377 hasRelatedWork W2369162477 @default.
• W4220764377 hasRelatedWork W2439875401 @default.
• W4220764377 hasRelatedWork W4238867864 @default.
• W4220764377 hasRelatedWork W2525756941 @default.
• W4220764377 hasVolume "104" @default.
• W4220764377 isParatext "false" @default.
• W4220764377 isRetracted "false" @default.
• W4220764377 workType "article" @default.